To ask the Secretary of State for Health and Social Care, whether the MHRA is considering the approval of vorasidenib for the treatment of low grade gliomas.
It is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products Regulatory Agency (MHRA) whic...
Vorasidenib